Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Immunological differences between primary and metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers.
Nature communications·2018
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Quantitative assessment of miR34a as an independent prognostic marker in breast cancer.
British journal of cancer·2014
Peptides.
Biotechnology (Reading, Mass.)·1995
A Novel Drug-Loaded Porous Parylene Electrode for Targeted Anti-Inflammatory Therapy and Hearing Preservation in Cochlear Implantation.
Advanced healthcare materials·2026
Prediction of Underexpansion Following Transcatheter Aortic Valve Implantation and Efficacy of Balloon Postdilatation.
Structural heart : the journal of the Heart Team·2026